An XMRV derived retroviral vector as a tool for gene transfer

Virology Journal

Volumn 8, Issue , 2011, Pages

  Cervantes Garcia, Daniel ^a,b   Rojas Martinez, Augusto ^b   Camerini, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

retroviral vector; transduction; XMRV

Indexed keywords

PLASMID VECTOR; PXC VECTOR; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN LNCAP; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; TRANSIENT EXPRESSION; VIRAL GENE DELIVERY SYSTEM; XENOTROPIC MULV RELATED VIRUS; CELL LINE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; METHODOLOGY; VIRUS ASSEMBLY;

GAMMARETROVIRUS; MURINE LEUKEMIA VIRUS;

CELL LINE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; VIRUS ASSEMBLY; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 79958070723     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-284     Document Type: Article

References (17)

1. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. KA Page NR Landau DR Littman, J Virol 1990 64 5270 5276 2214018 (Pubitemid 20364514)
2. Progress and problems with the use of viral vectors for gene therapy. CE Thomas A Ehrhardt MA Kay, Nat Rev Genet 2003 4 346 358 10.1038/nrg1066 12728277 (Pubitemid 36538359)
3. Design of retroviral vectors and helper cells for gene therapy. WS Hu VK Pathak, Pharmacol Rev 2000 52 493 511 11121508
4. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus. S Kim EJ Park SS Yu S Kim, J Virol Methods 2004 118 1 7 10.1016/j.jviromet.2004.01.010 15158062 (Pubitemid 38648768)
5. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. PL Sinn SL Sauter PB McCray Jr, Gene Ther 2005 12 1089 1098 10.1038/sj.gt.3302570 16003340 (Pubitemid 41030614)
6. In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice. L Xu T O'Malley MS Sands B Wang T Meyerrose ME Haskins KP Ponder, Mol Ther 2004 10 37 44 10.1016/j.ymthe.2004.04.010 15233940 (Pubitemid 38878147)
7. Transduction of human embryonic stem cells by ecotropic retroviral vectors. P Koch H Siemen A Biegler J Itskovitz-Eldor O Brüstle, Nucleic Acids Res 2006 34 120 10.1093/nar/gkl674 16998181
8. Lentiviral vectors in clinical trials: Current status. J D'Costa SG Mansfield LM Humeau, Curr Opin Mol Ther 2009 11 554 564 19806504
9. Use of HIV as a gene transfer vector. K Pluta MM Kacprzak, Acta Biochim Pol 2009 56 531 595 19936329
10. Gene Therapy Clinical Trials Worldwide. http://www.wiley.com//legacy/ wileychi/genmed/clinical/
11. An improved self-deleting retroviral vector derived from avian leukemia and sarcoma virus. C Torne-Celer K Moreau C Faure G Verdier C Ronfort, Arch Virol 2008 153 2233 2243 10.1007/s00705-008-0252-1 19018452
12. Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection. EI Marusich Z Parveen D Strayer M Mukhtar RC Dornburg RJ Pomerantz, Virology 2005 332 258 271 10.1016/j.virol.2004.11.012 15661158 (Pubitemid 40127247)
13. Sequences in the 5' leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell lines. FM Guesdon J Greatorex SR Rhee R Fisher E Hunter AM Lever, Virology 2001 288 81 88 10.1006/viro.2001.1061 11543660 (Pubitemid 32846476)
14. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. A Urisman RJ Molinaro N Fischer SJ Plummer G Casey EA Klein K Malathi C Magi-Galluzzi RR Tubbs D Ganem RH Silverman JL DeRisi, PLoS Pathog 2006 2 3 25 10.1371/journal.ppat.0020025 16609730
15. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. B Dong S Kim S Hong J Das Gupta K Malathi EA Klein D Ganem JL Derisi SA Chow RH Silverman, Proc Natl Acad Sci USA 2007 104 1655 1660 10.1073/pnas.0610291104 17234809 (Pubitemid 46214646)
16. Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells. S Bhosle S Suppiah R Molinaro Y Liang R Arnold W Diehl N Makarova J Blackwell J Petros D Liotta E Hunter H Ly, J Virol 2010 84 13 6288 6296 10.1128/JVI.00274-10 20410264
17. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. JJ Rodriguez SP Goff, J Virol 2010 84 5 2556 2562 10.1128/JVI.01969-09 20015990